共 50 条
Roflumilast for asthma: Weighing the evidence
被引:5
|作者:
Bateman, E. D.
[1
]
O'Byrne, P. M.
[2
]
Buhl, R.
[3
]
Rabe, K. F.
[4
,5
]
机构:
[1] Univ Cape Town, Lung Inst, Dept Med, Div Pulmonol, ZA-7925 Cape Town, South Africa
[2] McMaster Univ, Firestone Inst Resp Hlth, Dept Med, Hamilton, ON L8S 4L8, Canada
[3] Mainz Univ Hosp, Dept Pulm, Mainz, Germany
[4] LungClin, Grosshansdorf, Germany
[5] Univ Kiel, Dept Med, Kiel, Germany
关键词:
Asthma;
Roflumilast;
Safety;
Placebo;
FEV1;
ICS;
OBSTRUCTIVE PULMONARY-DISEASE;
PDE4 INHIBITOR ROFLUMILAST;
RANDOMIZED CLINICAL-TRIALS;
PHOSPHODIESTERASE-4;
INHIBITOR;
SPUTUM;
BRONCHODILATORS;
INFLAMMATION;
EFFICACY;
UPDATE;
D O I:
10.1016/j.pupt.2015.08.001
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
引用
收藏
页码:S1 / S3
页数:3
相关论文